Sildenafil (Viagra) is a vasodilator mainly used in the treatment of erectile dysfunction. Atrial or ventricular fibrillation may rarely occur as a side effect during sildenafil therapy. Although changes in inward rectifier potassium currents including I K1 are known to contribute to the pathogenesis of fibrillation, the effect of sildenafil on I K1 has not been studied. In experiments, Ba2+ is used as a specific inhibitor of I K1 at high concentrations (usually 100 µM). Being an environmental contaminant, it is also present in the human body; Ba2+ plasmatic concentrations up to 1.5 µM are usually reported in the general population. This study was primarily aimed to investigate changes of I K1 induced by sildenafil in a wide range of concentrations (0.1-100 µM). Additionally, the effect of combination of sildenafil and Ba2+ at selected clinically-relevant concentrations was tested, at 0.1 µM both on I K1 and on the action potential duration (APD). Experiments were performed by the whole-cell patch-clamp technique on enzymatically isolated rat ventricular cardiomyocytes, mostly at 23°C with the exception of APD measurements which were performed at 37°C as well. Sildenafil caused a significant, reversible, and concentration-dependent inhibition of I K1 that did not differ at -50 and -110 mV. Simultaneous application of sildenafil and Ba2+ at 0.1 µM revealed a massive inhibition of both inward and outward components of I K1 (this synergy was missing at other tested combinations). The combined effect at 0.1 µM (45.7 ± 5.7 and 43.0 ± 6.9% inhibition at -50 and -110 mV, respectively) was significantly higher than a simple sum of almost negligible effects of the individual substances and it led to a significant prolongation of APD at both 23 and 37°C. To our knowledge, similar potentiation of the drug-channel interaction has not been described. The observed massive inhibition of I K1 induced by a combined action of the vasodilator sildenafil and environmental contaminant Ba2+ at a low concentration and resulting in a significant APD prolongation may contribute to the genesis of arrhythmias observed in some patients treated with sildenafil.

Department of Physiology Faculty of Medicine Masaryk University Brno Czechia

Zobrazit více v PubMed

Alagem N., Dvir M., Reuveny E. (2001). Mechanism of Ba(2+) Block of a Mouse Inwardly Rectifying K+ Channel: Differential Contribution by Two Discrete Residues. J. Physiol. 534 (2), 381–393. 10.1111/j.1469-7793.2001.00381.x PubMed DOI PMC

Atienza F., Almendral J., Moreno J., Vaidyanathan R., Talkachou A., Kalifa J., et al. (2006). Activation of Inward Rectifier Potassium Channels Accelerates Atrial Fibrillation in Humans: Evidence for a Reentrant Mechanism. Circulation 114 (23), 2434–2442. 10.1161/CIRCULATIONAHA.106.633735 PubMed DOI

Awan G. M., Calderon E., Dawood G., Alpert M. A. (2000). Acute, Symptomatic Atrial Fibrillation after Sildenafil Citrate Therapy in a Patient with Hypertrophic Obstructive Cardiomyopathy. Am. J. Med. Sci. 320 (1), 69–71. 10.1097/00000441-200007000-00011 PubMed DOI

Beasley C. M., Jr., Mitchell M. I., Dmitrienko A. A., Emmick J. T., Shen W., Costigan T. M., et al. (2005). The Combined Use of Ibutilide as an Active Control with Intensive Electrocardiographic Sampling and Signal Averaging as a Sensitive Method to Assess the Effects of Tadalafil on the Human QT Interval. J. Am. Coll. Cardiol. 46 (4), 678–687. 10.1016/j.jacc.2005.05.036 PubMed DOI

Bebarova M., Matejovic P., Pasek M., Simurdova M., Simurda J. (2014). Dual Effect of Ethanol on Inward Rectifier Potassium Current Ik1 in Rat Ventricular Myocytes. J. Physiol. Pharmacol. 65 (4), 497–509. PubMed

Bhoelan B. S., Stevering C. H., van der Boog A. T., van der Heyden M. A. (2014). Barium Toxicity and the Role of the Potassium Inward Rectifier Current. Clin. Toxicol. (Phila) 52 (6), 584–593. 10.3109/15563650.2014.923903 PubMed DOI

Bosch R. F., Li G. R., Gaspo R., Nattel S. (1999). Electrophysiologic Effects of Chronic Amiodarone Therapy and Hypothyroidism, Alone and in Combination, on Guinea Pig Ventricular Myocytes. J. Pharmacol. Exp. Ther. 289 (1), 156–165. PubMed

Burks M., Stickel S., Galiè N. (2018). Pulmonary Arterial Hypertension: Combination Therapy in Practice. Am. J. Cardiovasc. Drugs 18 (4), 249–257. 10.1007/s40256-018-0272-5 PubMed DOI PMC

Chaumais M. C., Perrin S., Sitbon O., Simonneau G., Humbert M., Montani D. (2013). Pharmacokinetic Evaluation of Sildenafil as a Pulmonary Hypertension Treatment. Expert Opin. Drug Metab. Toxicol. 9 (9), 1193–1205. 10.1517/17425255.2013.804063 PubMed DOI

Chiang C. E., Luk H. N., Wang T. M., Ding P. Y. (2002). Effects of Sildenafil on Cardiac Repolarization. Cardiovasc. Res. 55 (2), 290–299. 10.1016/S0008-6363(02)00438-8 PubMed DOI

Croom K. F., Curran M. P. (2008). Sildenafil: a Review of its Use in Pulmonary Arterial Hypertension. Drugs 68 (3), 383–397. 10.2165/00003495-200868030-00009 PubMed DOI

Dallas C. E., Williams P. L. (2001). Barium: Rationale for a New Oral Reference Dose. J. Toxicol. Environ. Health B Crit. Rev. 4 (4), 395–429. 10.1080/109374001753146216 PubMed DOI

De Boer T. P., Houtman M. J., Compier M., Van Der Heyden M. A. (2010). The Mammalian K(IR)2.X Inward Rectifier Ion Channel Family: Expression Pattern and Pathophysiology. Acta Physiol. (Oxf) 199, 243–256. 10.1111/j.1748-1716.2010.02108.x PubMed DOI

Dhamoon A. S., Jalife J. (2005). The Inward Rectifier Current (Ik1) Controls Cardiac Excitability and Is Involved in Arrhythmogenesis. Heart Rhythm 2 (3), 316–324. 10.1016/j.hrthm.2004.11.012 PubMed DOI

Dustan Sarazan R., Crumb W. J., Jr., Beasley C. M., Jr., Emmick J. T., Ferguson K. M., Strnat C. A., et al. (2004). Absence of Clinically Important HERG Channel Blockade by Three Compounds that Inhibit Phosphodiesterase 5--sildenafil, Tadalafil, and Vardenafil. Eur. J. Pharmacol. 502 (3), 163–167. 10.1016/j.ejphar.2004.09.005 PubMed DOI

Ehrlich J. R. (2008). Inward Rectifier Potassium Currents as a Target for Atrial Fibrillation Therapy. J. Cardiovasc. Pharmacol. 52 (2), 129–135. 10.1097/FJC.0b013e31816c4325 PubMed DOI

Galiè N., Manes A., Negro L., Palazzini M., Bacchi-Reggiani M. L., Branzi A. (2009). A Meta-Analysis of Randomized Controlled Trials in Pulmonary Arterial Hypertension. Eur. Heart J. 30 (4), 394–403. 10.1093/eurheartj/ehp022 PubMed DOI PMC

Geelen P., Drolet B., Rail J., Bérubé J., Daleau P., Rousseau G., et al. (2000). Sildenafil (Viagra) Prolongs Cardiac Repolarization by Blocking the Rapid Component of the Delayed Rectifier Potassium Current. Circulation 102 (3), 275–277. 10.1161/01.CIR.102.3.275 PubMed DOI

Gruenig E., Michelakis E., Vachiéry J. L., Vizza C. D., Meyer F. J., Doelberg M., et al. (2009). Acute Hemodynamic Effects of Single-Dose Sildenafil when Added to Established Bosentan Therapy in Patients with Pulmonary Arterial Hypertension: Results of the COMPASS-1 Study. J. Clin. Pharmacol. 49 (11), 1343–1352. 10.1177/0091270009341182 PubMed DOI

Hayashi K., Minezaki K. K., Narukawa M., Ookubo M., Mitsuhashi T., Shimada K. (1999). Atrial Fibrillation and Continuous Hypotension Induced by Sildenafil in an Intermittent WPW Syndrome Patient. Jpn. Heart J. 40 (6), 827–830. 10.1536/jhj.40.827 PubMed DOI

Heijman J., Voigt N., Nattel S., Dobrev D. (2014). Cellular and Molecular Electrophysiology of Atrial Fibrillation Initiation, Maintenance, and Progression. Circ. Res. 114 (9), 1483–1499. 10.1161/CIRCRESAHA.114.302226 PubMed DOI

Hung Y. M., Chung H. M. (2004). Acute Self-Poisoning by Ingestion of Cadmium and Barium. Nephrol. Dial. Transpl. 19 (5), 1308–1309. 10.1093/ndt/gfh169 PubMed DOI

Hyland R., Roe E. G., Jones B. C., Smith D. A. (2001). Identification of the Cytochrome P450 Enzymes Involved in the N-Demethylation of Sildenafil. Br. J. Clin. Pharmacol. 51 (3), 239–248. 10.1046/j.1365-2125.2001.00318.x PubMed DOI PMC

Jackson G., Benjamin N., Jackson N., Allen M. J. (1999). Effects of Sildenafil Citrate on Human Hemodynamics. Am. J. Cardiol. 83 (5A), 13C–20C. 10.1016/s0002-9149(99)00043-0 PubMed DOI

Kessler A., Sollie S., Challacombe B., Briggs K., Van Hemelrijck M. (2019). The Global Prevalence of Erectile Dysfunction: a Review. BJU Int. 124 (4), 587–599. 10.1111/bju.14813 PubMed DOI

Kravchenko J., Darrah T. H., Miller R. K., Lyerly H. K., Vengosh A. (2014). A Review of the Health Impacts of Barium from Natural and Anthropogenic Exposure. Environ. Geochem. Health 36 (4), 797–814. 10.1007/s10653-014-9622-7 PubMed DOI

Langtry H. D., Markham A. (1999). Sildenafil. Drugs 57 (6), 967–989. 10.2165/00003495-199957060-00015 PubMed DOI

Morganroth J., Ilson B. E., Shaddinger B. C., Dabiri G. A., Patel B. R., Boyle D. A., et al. (2004). Evaluation of Vardenafil and Sildenafil on Cardiac Repolarization . Am. J. Cardiol. 93 (11), 1378–A6. 10.1016/j.amjcard.2004.02.034 PubMed DOI

Muirhead G. J., Wulff M. B., Fielding A., Kleinermans D., Buss N. (2000). Pharmacokinetic Interactions between Sildenafil and Saquinavir/ritonavir. Br. J. Clin. Pharmacol. 50 (2), 99–107. 10.1046/j.1365-2125.2000.00245.x PubMed DOI PMC

Nichols D. J., Muirhead G. J., Harness J. A. (2002). Pharmacokinetics of Sildenafil after Single Oral Doses in Healthy Male Subjects: Absolute Bioavailability, Food Effects and Dose Proportionality. Br. J. Clin. Pharmacol. 53 (Suppl. 1), 5S–12S. 10.1046/j.0306-5251.2001.00027.x PubMed DOI PMC

Ogura T., Shuba L. M., McDonald T. F. (1995). Action Potentials, Ionic Currents and Cell Water in guinea Pig Ventricular Preparations Exposed to Dimethyl Sulfoxide. J. Pharmacol. Exp. Ther. 273 (3), 1273–1286. PubMed

Oskarsson A., Reeves A. L. (2007). “Barium,” in Handbook on the Toxicology of Metals. Editors Nordberg G. F., Fowler B. A., Nordberg M., Friberg L. T.. Third Edition (Academic Press; ), 407–414. 10.1016/B978-012369413-3/50075-6 DOI

Panama B. K., McLerie M., Lopatin A. N. (2007). Heterogeneity of Ik1 in the Mouse Heart. Am. J. Physiol. Heart Circ. Physiol. 293 (6), H3558–H3567. 10.1152/ajpheart.00419.2007 PubMed DOI

Rasmussen J. G., Toft E., Frøbert O. (2007). Ventricular Tachycardia after Administration of Sildenafil Citrate: a Case Report. J. Med. Case Rep. 1, 65. 10.1186/1752-1947-1-65 PubMed DOI PMC

Reilly L., Eckhardt L. L. (2021). Cardiac Potassium Inward Rectifier Kir2: Review of Structure, Regulation, Pharmacology, and Arrhythmogenesis. Heart Rhythm 18 (8), 1423–1434. 10.1016/j.hrthm.2021.04.008 PubMed DOI PMC

Ruhela M., Bagarhatta R. (2018). Atrial Fibrillation: a Rare but Probable Adverse Effect of Sildenafil. Int. J. Basic Clin. Pharmacol. 7 (4), 813–815. 10.18203/2319-2003.ijbcp20181192 DOI

Schram G., Pourrier M., Wang Z., White M., Nattel S. (2003). Barium Block of Kir2 and Human Cardiac Inward Rectifier Currents: Evidence for Subunit-Heteromeric Contribution to Native Currents. Cardiovasc. Res. 59 (2), 328–338. 10.1016/S0008-6363(03)00366-3 PubMed DOI

Tracqui A., Miras A., Tabib A., Raul J. S., Ludes B., Malicier D. (2002). Fatal Overdosage with Sildenafil Citrate (Viagra): First Report and Review of the Literature. Hum. Exp. Toxicol. 21 (11), 623–629. 10.1191/0960327102ht302oa PubMed DOI

Tse G. (2016). Mechanisms of Cardiac Arrhythmias. J. Arrhythm 32 (2), 75–81. 10.1016/j.joa.2015.11.003 PubMed DOI PMC

Varma A., Shah K. B., Hess M. L. (2012). Phosphodiesterase Inhibitors, Congestive Heart Failure, and Sudden Death: Time for Re-evaluation. Congest. Heart Fail. 18 (4), 229–233. 10.1111/j.1751-7133.2012.00293.x PubMed DOI

Veloso H. H., de Paola A. A. (2005). Atrial Fibrillation after Vardenafil Therapy. Emerg. Med. J. 22 (11), 823. 10.1136/emj.2004.015982 PubMed DOI PMC

Zhou H., Chepilko S., Schütt W., Choe H., Palmer L. G., Sackin H. (1996). Mutations in the Pore Region of ROMK Enhance Ba2+ Block. Am. J. Physiol. 271 (6), C1949–C1956. 10.1152/ajpcell.1996.271.6.C1949 PubMed DOI

Sildenafil affects the human Kir2.1 and Kir2.2 channels at clinically relevant concentrations: Inhibition potentiated by low Ba2